Table 4. Treatment in Kawasaki- like MIS-C and MIS-C patients.
| Treatment | Total(N = 225) | Kawasaki- like MIS-C | MIS-C | p-value |
|---|---|---|---|---|
| (n = 58) | (n = 167) | |||
| IVIG | 211(94.2) | 57(98.3) | 154(92.8) | 0.12 |
| Steroids | 175(77.8) | 37(63.8) | 138(82.6) | 0.003 |
| Steroids and IVIG | 161(71.9) | 36(62.1) | 125(75.3) | 0.05 |
| Antiplatelet | 154(68.4) | 49(84.5) | 105(62.8) | 0.002 |
| Anticoagulation | 123(54.7) | 27(46.5) | 96(57.5) | 0.15 |
| Antibiotics | 123(54.7) | 50(86.2) | 73(43.7) | <0.001 |
| Vasoactive medication | 100(44.4) | 26(44.8) | 74(44.3) | 0.94 |
| Low flow nasal cannula | 90(40) | 21(36.2) | 69(41.3) | 0.49 |
| Second IVIG | 38(16.9) | 4(6.90) | 34(20.4) | 0.01 |
| Antivirals | 38(16.9) | 20(34.5) | 18(10.8) | <0.001 |
| Intubation | 22(9.78) | 2(3.45) | 20(11.9) | 0.06 |
| Mechanical ventilation | 21(9.33) | 2(3.45) | 19(11.4) | 0.07 |
| High flow nasal cannula | 13(5.78) | 0 | 13(7.78) | 0.02 |
| Immune modulators | 12(5.33) | 1(1.72) | 11(6.59) | 0.15 |
| Noninvasive ventilation | 5(2.22) | 0 | 5(2.99) | 0.33 |
| Dialysis | 2(0.89) | 0 | 2(1.20) | 1 |